Catalyst Wire Dossier Catalyst Wire Dossier

VIJOICE

ALPELISIB · Novartis Pharmaceuticals Corporation
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for VIJOICE, covering 2022-04-05 to 2026-08-26. Get the full timeline:

Most recent: EMA Authorised: Vijoice (alpelisib) — Novartis Europharm Limited

See pricing